Structural Heart features studies on ASD closure and disparities in Watchman device access

March 12, 2019

NEW YORK - March 12, 2019-The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team features original research articles on readmissions after atrial septal defect (ASD) closure and socioeconomic disparities in access to the Watchman device in patients with atrial fibrillation (AF).

Structural Heart, the official journal of CRF, is led by a distinguished Editorial Board of recognized international experts in the field. The journal is dedicated to disseminating the latest research and information to members of the Heart Team, as well as the wider medical community interested in structural heart disorders. The journal is now indexed on Embase, a biomedical research database from Elsevier.

"The second issue of Volume 3 features two research papers that may impact the treatment of atrial septal defects and atrial fibrillation," said Anthony N. DeMaria, MD, Editor-in-Chief of the journal and the Judith and Jack White Chair in Cardiology and Founding Director of the Sulpizio Cardiovascular Center at the University of California, San Diego. "A paper by Mojadidi et al evaluates readmissions data after ASD closure and indicates that compared with surgical repairs, percutaneous ASD closures are associated with lower all-cause mortality, major and minor complications, and length of hospital stay. A paper by Kupsky et al examines data regarding racial, economic, and social disparities in AF patients at elevated risk for bleeding referred to Watchman insertion."

Below are brief descriptions of the two original articles highlighted in this issue.

Incidence and Causes of 30-day Readmissions after Surgical Versus Percutaneous Secundum Atrial Septal Defect Closure: A United States Nationwide Analysis
M. Mojadidi et al.

Editorial: As If Percutaneous ASD Closure Needed More Proof
T. Jones

Researchers evaluated the incidence and reasons of 30-day readmissions following surgical versus percutaneous secundum ASD closure. They found that percutaneous ASD closure is associated with lower rates of 30-day readmissions, mean length of hospital stay, and hospital charges as compared with surgical closure.

Socioeconomic Disparities in Access for Watchman Device Insertion in Patients with Atrial Fibrillation and at Elevated Risk of Bleeding
D. Kupsky et al.

This single-center retrospective case-control study examined socioeconomic and racial disparities among select atrial fibrillation (AF) patients who did or did not receive Watchman device placement. Researchers found that socioeconomic and racial disparities exist in patients with non-valvular AF at elevated risk of bleeding. African-American patients with lower income and Medicaid were less likely to be referred for the Watchman device.
About CRF and Structural Heart

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve the survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease. For more information, visit

Structural Heart: The Journal of the Heart Team is the official journal of CRF. It is a unique, international, and peer-reviewed journal focusing on the diagnosis and treatment of diseases of the heart valves, myocardium, and great vessels, as well as congenital heart disease. The journal covers topics such as transcatheter procedures, cardiovascular surgery, drug treatment, basic and translational science, imaging, and innovation (new devices, therapies, and first-in-man). The journal is now indexed on Embase, a biomedical research database from Elsevier. For more information, visit

Cardiovascular Research Foundation

Related Atrial Fibrillation Articles from Brightsurf:

Atrial fibrillation less deadly than it used to be, but still cause for concern: BU study
A first-of-its-kind study by researchers from the Boston University School of Public Health (BUSPH) shows a decline in deaths related to atrial fibrillation (irregular heartbeat) over the last 45 years.

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy
Volume 11, Issue 25 of Oncotarget reported that Administration of landiolol hydrochloride was found to be associated with reduced incidence of atrial fibrillation after esophagectomy for esophageal cancer in our previous randomized controlled trial.

People with atrial fibrillation live longer with exercise
More than 100,000 Norwegians have atrial fibrillation. They should be actively exercising for their health.

Atrial fibrillation among overweight people is not due to fat
In a recently published study, researchers from Aarhus University document that the risk of atrial fibrillation is not linked to the amount of body fat, but instead to large muscle mass, or more precisely, a high fat-free weight

Eating more protein could help ward off atrial fibrillation in women
Women who ate slightly more than the recommended daily amount of protein were significantly less likely to develop atrial fibrillation (AFib), a dangerous heart rhythm disorder that can lead to stroke and heart failure, when compared with those who consumed less protein, according to research being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

Zebrafish teach researchers more about atrial fibrillation
Genetic research in zebrafish at the University of Copenhagen has surprised the researchers behind the study.

Personalized medicine for atrial fibrillation
The study, published in Europace, uses signals from implantable devices -- pacemakers and defibrillators -- to analyze electrical signals in the heart during episodes of atrial fibrillation.

Prescribing anticoagulants in the ED for atrial fibrillation increases long-term use by 30%
Patients prescribed anticoagulants after a diagnosis of atrial fibrillation in the emergency department are more likely to continue long-term use of medications to treat the condition, according to research published in CMAJ (Canadian Medical Association Journal).

Anticoagulant benefits for atrial fibrillation decrease with age
The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

Research improves understanding of mechanism of atrial fibrillation
Mouse model studies show that noncoding DNA regions linked to atrial fibrillation risk can display long-range regulatory functions directed at Pitx2 gene and in this way predispose to the condition.

Read More: Atrial Fibrillation News and Atrial Fibrillation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to